Pharmacogenomics and Personalized Medicine

The practices of personalized medicine are to maximize the therapeutic effects of likelihood and to minimize the risk of drug toxicity for an individual patient. Pharmacogenomics is the study of the genome in drug response. The genetic disorder occurrence is quite rare in population; some might be hereditary while the others are caused by mutations. Disease-specific epigenetic signatures such as DNA methylation, hydroxymethylation, and non-coding RNAs are now being utilized clinically for prognostics and diagnostics, while an expanding collection of genetically aberrant, abnormally expressed or chromatin-interacting epigenetic enzymes are positioned as promising targets for therapeutic intervention. Scientists also recognize that even as the knowledge base continues to expand, the clinical translation of that knowledge still requires empirical evidence, generated for a particular disease and drug combination, before treatment can be customized to a patient's genotype.

 

  • Genomic DNA and mRNA
  • Serotonin transporter gene

Related Conference of Pharmacogenomics and Personalized Medicine

April 03-04, 2023

International Conference on Aging and Gerontology

Rome, Aland Islands
May 03-04, 2023

16th World Congress on Stem Cell Research

Paris, France
May 03-04, 2023

Global Conference on Cell and Gene Therapy

Paris, France
June 09-10, 2023

10th World Congress on Epigenetics and Chromosome

Valencia, Spain
June 28-29, 2023

27th Global Congress on Biotechnology

Toronto, Canada
September 25-26, 2023

19th Global Summit on Stem Cell & Regenerative Medicine

Zurich, Switzerland
October 19-20, 2023

5th Annual summit on Cell Signaling and Cancer Therapy

Montreal, Canada
December 07-08, 2023

17th International Conference on Genomics & Pharmacogenomics

San Francisco, USA

Pharmacogenomics and Personalized Medicine Conference Speakers

    Recommended Sessions

    Related Journals

    Are you interested in